Last reviewed · How we verify

SARS-CoV-2 VLP Vaccine-Wuhan

Ihsan GURSEL, PhD, Prof. · Phase 2 active Biologic

SARS-CoV-2 VLP Vaccine-Wuhan is a Biologic drug developed by Ihsan GURSEL, PhD, Prof.. It is currently in Phase 2 development. Also known as: Authentic VLP Vaccine.

At a glance

Generic nameSARS-CoV-2 VLP Vaccine-Wuhan
Also known asAuthentic VLP Vaccine
SponsorIhsan GURSEL, PhD, Prof.
ModalityBiologic
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about SARS-CoV-2 VLP Vaccine-Wuhan

What is SARS-CoV-2 VLP Vaccine-Wuhan?

SARS-CoV-2 VLP Vaccine-Wuhan is a Biologic drug developed by Ihsan GURSEL, PhD, Prof..

Who makes SARS-CoV-2 VLP Vaccine-Wuhan?

SARS-CoV-2 VLP Vaccine-Wuhan is developed by Ihsan GURSEL, PhD, Prof. (see full Ihsan GURSEL, PhD, Prof. pipeline at /company/ihsan-gursel-phd-prof).

Is SARS-CoV-2 VLP Vaccine-Wuhan also known as anything else?

SARS-CoV-2 VLP Vaccine-Wuhan is also known as Authentic VLP Vaccine.

What development phase is SARS-CoV-2 VLP Vaccine-Wuhan in?

SARS-CoV-2 VLP Vaccine-Wuhan is in Phase 2.

Related